[JAGX] Jaguar Animal Health, Inc.


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 0.65 Change: -0 (-0.03%)
Ext. hours: Change: 0 (0%)

chart JAGX

Refresh chart

Strongest Trends Summary For JAGX

JAGX is in the medium-term down -62% in 3 months and down -92% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.24 M Cash From Investing Activities Cash From Operating Activities-1.34 M Gross Profit30 K
Net Profit-3.94 M Operating Profit-2.68 M Total Assets4.84 M Total Current Assets3.98 M
Total Current Liabilities9.21 M Total Debt1.7 M Total Liabilities9.21 M Total Revenue60 K
Technical Data
High 52 week4.85 Low 52 week0.13 Last close0.33 Last change-4.64%
RSI66.72 Average true range0.05 Beta0.27 Volume137.04 K
Simple moving average 20 days21.99% Simple moving average 50 days-11.63% Simple moving average 200 days-73.15%
Performance Data
Performance Week21.85% Performance Month-8.86% Performance Quart-42.91% Performance Half-75.99%
Performance Year157.23% Performance Year-to-date43.79% Volatility daily9.66% Volatility weekly21.6%
Volatility monthly44.26% Volatility yearly153.33% Relative Volume56.92% Average Volume775.38 K
New High New Low-0.02%


2019-01-09 08:00:00 | Jaguar Health Receives First Order for First-Generation of Equilevia, the Company's Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine Athletes

2019-01-07 08:00:00 | Jaguar Health Provides Fourth Quarter 2018 Commercial Sales Updates

2019-01-03 08:00:00 | Jaguar Health to Present at Biotech Showcase 2019 in San Francisco

2019-01-02 08:00:00 | Jaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q'18 Performance

2018-12-06 08:00:00 | Jaguar Health, Inc. Engages T.R. Winston & Company to Advise on Collaboration, Licensing and Development Activities Related to Mytesi and Crofelemer

2018-11-14 20:05:00 | Jaguar Health, Inc. Reports Third-Quarter 2018 Results

2018-11-13 08:00:00 | Reminder: Jaguar Health, Inc. Will Release 3Q'18 Financial Results After Market on November 14th

2018-10-29 09:00:00 | The Brilliance Behind a Global Operator of Crypto Exchanges BitMax: Understanding the Trans-Fee Mining Model

2018-10-29 09:00:00 | Jaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14th

2018-10-24 09:00:00 | Jaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, Florida

2018-10-18 09:25:00 | Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals — Discovering Underlying Factors of Influence

2018-10-02 06:00:00 | Jaguar Health Announces Pricing of $9 Million Underwritten Public Offering

2018-09-26 10:30:00 | These Biotech and Cannabis Stocks Are Skyrocketing

2018-09-25 14:40:00 | Jaguar Health's stock triples after licensing deal, has been halted 13 times for volatility

2018-09-24 16:36:28 | Knight Therapeutics and Jaguar Health Announce Strategic Partnership

2018-09-24 16:30:00 | Knight Therapeutics and Jaguar Health Announce Strategic Partnership

2018-08-27 07:55:00 | Detailed Research: Economic Perspectives on The Michaels Companies, Glu Mobile, Natus Medical, Progenics Pharmaceuticals, QuinStreet, and Jaguar Health — What Drives Growth in Today's Competitive Landscape

2018-07-25 08:00:00 | RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®

2018-07-24 09:00:00 | New Analysis of Data in Over 21,000 People Living with HIV Shows Diarrhea Continues to be an Issue and Has Not Declined Significantly Over Time

2018-07-18 07:20:00 | Free Daily Technical Summary Reports on Iovance Biotherapeutics and Three Other Biotech Stocks

2018-07-16 09:00:00 | Napo Pharmaceuticals to Present New Data at the 22nd International AIDS 2018 Conference

2018-07-16 08:00:00 | Today's Research Reports on Trending Tickers: Zogenix and Momenta Pharmaceuticals

2018-07-12 09:00:00 | Jaguar Health, Inc. Provides Second Quarter 2018 Financial Updates

2018-06-28 09:00:00 | Jaguar Health NASDAQ: JAGX Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product

2018-06-28 09:00:00 | RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

2018-06-25 07:45:00 | Research Report Identifies Glu Mobile, Reliance Steel & Aluminum, FedEx, Jaguar Animal Health, Box, and VirnetX Holding with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-06-20 09:00:00 | Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors

2018-06-18 09:00:00 | Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors

2018-06-15 07:09:00 | Iovance Biotherapeutics and Three Additional Biotech Stocks on Our Research Desk's Radar

2018-06-12 09:00:00 | Napo Pharmaceuticals Presents New Data at the 13th International Conference on HIV Treatment and Prevention Adherence Regarding the Use of Mytesi Crofelemer to Treat Noninfectious Diarrhea in HIV Patients

2018-06-03 08:34:19 | Is Jaguar Health Inc’s NASDAQ:JAGX Balance Sheet Strong Enough To Weather A Storm?

2018-06-01 09:00:00 | Jaguar Health, Inc. Announces 1-for-15 Reverse Stock Split

2018-05-29 09:00:00 | Jaguar Health Appoints Robert J. Griffing Chief Commercialization Officer of Jaguar Subsidiary Napo Pharmaceuticals

2018-05-18 17:24:00 | Jaguar Health, Inc. Reports First-Quarter 2018 Operational Updates and Voting Results from 2018 Annual Meeting of Stockholders

2018-05-15 11:15:18 | Jaguar Health Inc NASDAQ:JAGX: Does The Earnings Decline Make It An Underperformer?

2018-05-15 09:00:00 | ''Under Pressure'' Episode of Merce Uses Comedy to Help People Living with HIV Talk About Diarrhea

2018-05-14 07:10:00 | Free Breakfast Technical Briefing on Intrexon and Three Other Biotech Stocks

2018-05-07 08:15:00 | Research Report Identifies Jaguar Animal Health, Dollar Tree, WPX Energy, Abaxis, Lear, and Baker Hughes with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-04-19 09:00:00 | Experts Highlight that Immune System Activation in Aging Patients Living with HIV/AIDS Triggers Effects Such as _Leaky Gut_, Which Can Lead to Diarrhea

2018-04-10 09:00:00 | Jaguar Subsidiary Napo Pharmaceuticals Signs Agreement with the ADAP Crisis Task Force for Mytesi

2018-04-09 09:00:00 | Recent Publications Indicate that Diarrhea is a Significant and Serious Issue in HIV

2018-04-02 09:00:00 | Jaguar Health Appoints Jonathan B. Siegel to Board of Directors

2018-03-26 06:30:00 | Jaguar Health Announces Up to $16.2 Million in Equity Financings in Separate Private Placement Investments, Including Investment by Sagard Capital Partners, L.P., to Continue Commercialization of FDA-Approved Mytesi

2018-03-13 19:02:21 | Why Jaguar Health Inc’s NASDAQ:JAGX CEO Pay Matters To You

2018-03-13 15:00:00 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Jaguar Health, Inc.

2018-03-13 08:05:00 | Jaguar Health, Pipeline Review, Analyst Ratings, Milestones

2018-03-09 08:10:00 | Today’s Research Reports on Stocks to Watch: Atossa Genetics and Jaguar Health

2018-03-08 09:00:00 | FDA Indicates that Jaguar's Reasonable Expectation of Effectiveness Technical Section is Complete for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs

2018-03-05 08:10:00 | Report: Developing Opportunities within TripAdvisor, Glu Mobile, KeyCorp, SMART SAND INC, Jaguar Animal Health, and Cleveland-Cliffs — Future Expectations, Projections Moving into 2018

2018-03-02 09:00:00 | Jaguar Health Subsidiary, Napo Pharmaceuticals, Signs Agreement with Pharmacy Services Provider _Transition Patient Services_ to Establish Nationwide Pilot _Mytesi Direct_ Program